{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/67ef2a1fd4b40d7b306ad5be?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Friday, April 4, 2025","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1743727034748-86c4393e-7527-4c90-b9b5-b7d5a64ef66c.jpeg?height=200","description":"<p>The Federal Trade Commission has paused its suit against the nation’s biggest pharmacy benefit managers.&nbsp;States sue the Trump Administration after it abruptly cuts $11 billion in funding for public health initiatives.&nbsp;&nbsp;And, Eli Lilly says it is not affiliated with Hims &amp; Hers after the telehealth company announces it will sell the drugmaker’s popular weight loss drug Zepbound. We’ll get those stories—and more—coming up on today’s episode of the Gist Healthcare podcast.&nbsp;</p><p><br></p>","author_name":"Gist Healthcare Daily"}